Renal colic. Unspecified renal colic
Conditions
Interventions
Intervention 1: Control group: Renal colic patients will receive 1 g of IV normal saline with 0.05 mg/kg of IM morphine, and their level of pain will be assessed pre- and 30 minutes post-intervention
Treatment - Drugs
Control group: Renal colic patients will receive 1 g of IV normal saline with 0.05 mg/kg of IM morphine, and their level of pain will be assessed pre- and 30 minutes post-intervention based on Visual
Intervention group: Renal colic patients will receive 1 g of IV apotel (acetaminophen injection made of COMBINO PHARM company) with 0.05 mg/kg of IM morphine, and their level of pain will be assessed
Sponsors
Vice Chancellor for Research of Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Renal colic patients; having a weight between 50 and 80 kg; aged between 18 and 50 years. Exclusion criteria: History of allergy to narcotics or acetaminophen; chills and fever; urinary tract infection based on laboratory findings; history of drug abuse, receiving narcotics or other analgesics during six hours before admission; pregnancy; history of renal, cardiac, respiratory, or hepatic failure, history of renal transplantation; abdominal aortic aneurysm; history of hypertension or hemodynamic instability.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: Pre- and 30 minutes post-intervention. Method of measurement: Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Side-effects of pharmaceuticals, include nausea, vomiting, hypotension, itching and drowsiness. Timepoint: Half an hour after the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Sirous
Arak University of Medical Sciences
Outcome results
None listed